1. Home
  2. OBIO vs USBC Comparison

OBIO vs USBC Comparison

Compare OBIO & USBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$3.95

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

USBC

USBC Inc.

HOLD

Current Price

$0.49

Market Cap

221.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBIO
USBC
Founded
2017
N/A
Country
United States
Employees
N/A
24
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
221.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OBIO
USBC
Price
$3.95
$0.49
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$14.25
N/A
AVG Volume (30 Days)
219.1K
N/A
Earning Date
11-10-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,818,000.00
N/A
Revenue This Year
$36.66
N/A
Revenue Next Year
$2.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.46
N/A
52 Week Low
$2.20
N/A
52 Week High
$6.02
N/A

Technical Indicators

Market Signals
Indicator
OBIO
USBC
Relative Strength Index (RSI) 45.48 34.17
Support Level $3.46 $0.43
Resistance Level $4.24 $0.54
Average True Range (ATR) 0.31 0.07
MACD -0.02 -0.01
Stochastic Oscillator 45.70 4.89

Price Performance

Historical Comparison
OBIO
USBC

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About USBC USBC Inc.

USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.

Share on Social Networks: